425
Participants
Start Date
January 31, 2003
Primary Completion Date
June 30, 2004
Study Completion Date
June 30, 2004
Extended-release Bupropion Hydrochloride
GSK Investigational Site, New York
GSK Investigational Site, Wilmington
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Raleigh
GSK Investigational Site, Marietta
GSK Investigational Site, Smyrna
GSK Investigational Site, Orlando
GSK Investigational Site, Nashville
GSK Investigational Site, Cleveland
GSK Investigational Site, Baton Rouge
GSK Investigational Site, Oklahoma City
GSK Investigational Site, Bellaire
GSK Investigational Site, San Antonio
GSK Investigational Site, Boise
GSK Investigational Site, Salt Lake City
GSK Investigational Site, Phoenix
GSK Investigational Site, Scottsdale
GSK Investigational Site, Berkeley
GSK Investigational Site, Yakima
GSK Investigational Site, Middletown
GSK Investigational Site, Braintree
GSK Investigational Site, Piscataway
GSK Investigational Site, San Antonio
GSK Investigational Site, San Antonio
Lead Sponsor
GlaxoSmithKline
INDUSTRY